Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
WuXi AppTec
CRO
WuXi AppTec posts sales decline but picks up new business in Q3
With the specter of the BIOSECURE Act clouding its future, China’s WuXi AppTec sustained its fourth straight quarter with a revenue decline.
Kevin Dunleavy
Oct 29, 2024 8:25am
100 days with John Crowley: Behind BIO’s new structure & vision
Jun 25, 2024 9:05am
China's Stemirna raises $188M to fund mRNA COVID-19 vaccine
Jun 4, 2021 8:25am
WuXi AppTec sees growth for CRO, clinical work
Aug 19, 2020 7:40am
Simcha debuts with $25M to advance custom-built IL-18 for cancer
Jun 24, 2020 11:00am
Juno-WuXi AppTec JV JW Therapeutics nabs $100M for cell therapy
Jun 11, 2020 8:05am
